GRAIL, Inc. GRAL Business Segments — Total Costs & Expenses
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by GRAIL, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The official record: GRAIL, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about GRAIL, Inc.'s business segments — total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is GRAIL, Inc.'s business segments — total costs & expenses?
- GRAIL, Inc. (GRAL) reported business segments — total costs & expenses of $176.55M in Q1 2026.
- How has GRAIL, Inc.'s business segments — total costs & expenses changed year-over-year?
- GRAIL, Inc.'s business segments — total costs & expenses decreased by 4.8% year-over-year, from $185.44M to $176.55M.
- What is the long-term trend for GRAIL, Inc.'s business segments — total costs & expenses?
- Over 3 years (2022 to 2025), GRAIL, Inc.'s business segments — total costs & expenses has grown at a -49.5% compound annual growth rate (CAGR), from $5.5B to $709.34M.
- What does business segments — total costs & expenses mean?
- This represents the total aggregate operating costs and expenses incurred by the specific business segment during the reporting period. It encompasses all direct and indirect expenditures, including research and development, clinical trial costs, and administrative overhead required to support the segment's operations. Monitoring this metric helps assess the operational scale and cost structure efficiency of the business unit.